PHILADELPHIA (WPVI) -- There's another disease to add to the list of smoking-related ailments. But for doctors, they are still learning about CPFE or Combined Pulmonary Fibrosis and Emphysema. For ...

Objectives There is a lack of knowledge about whether occupational exposures increase the risk of emphysema, especially in ...

David Lynch is promising to “never retire” after revealing he suffers from emphysema. In a new interview with Sight & Sound magazine (via The Independent), Lynch shared the diagnosis due to years of ...

Legendary filmmaker David Lynch said he uses a supplemental oxygen tank now because of emphysema caused by decades of smoking. The “Blue Velvet” director revealed in August he was suffering from ...

David Lynch, best known for the TV series “Twin Peaks” and “Mulholland Drive,” is now “homebound” due to emphysema. The director made the revelation during an interview with Sight and Sound magazine. ...

The filmmaker took to X to clarify comments he made about his limited mobility in a recent "Sight & Sound" cover story. David Lynch has set the record straight over speculation that his filmmaking ...

Ty Roush is a breaking news reporter based in New York City. Emphysema and airway inflammation are more common among marijuana smokers than cigarette smokers, according to a study of a small group of ...

The name David Lynch conjures up many images. Cherry pie. Black coffee. Spikey white hair. Backward-talking little people. Dennis Hopper with an oxygen tank. Whatever the baby was in Eraserhead. Just ...

David Lynch, the iconic screenwriter and director behind surrealist staples “Twin Peaks” and “Eraserhead,” has been diagnosed with emphysema — and he says it has taken a toll on his ability to direct.

The director, 78, confirmed the diagnosis in a social media post after revealing in a magazine interview that he would be limited to directing remotely. By Alexandra E. Petri David Lynch, co-creator ...

The emphysema market is anticipated to grow steadily, fueled by a range of emerging therapies under development. Leading candidates like SAR447537 (Sanofi), Alvelestat (Mereo BioPharma), BEAM-302 ...